Skip to main content
ImmuneCited

Vitamin D 用于 自身免疫性病症

A 证据 多项大型临床试验一致显示出显著的益处。

The VITAL trial (25,871 participants over 5 years) demonstrated vitamin D supplementation at 2,000 IU/day may reduce autoimmune disease risk by 22%. This represents one of the largest and longest randomized trials of vitamin D for autoimmune disease prevention.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dvitamin\u002Dd\u0026condition\u003Dautoimmune\u002Dconditions'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

结论

The VITAL trial (25,871 participants over 5 years) demonstrated vitamin D supplementation at 2,000 IU/day may reduce autoimmune disease risk by 22%. This represents one of the largest and longest randomized trials of vitamin D for autoimmune disease prevention.

Key Study Findings

Review
Impact of Nutritional Diet Therapy on Rheumatoid Arthritis Disease Activity.
Dose: None vs: None Outcome: rheumatoid arthritis disease activity modulation through diet 效果: None None

研究人群: patients with rheumatoid arthritis

Review
The Role of Nutrition in the Development, Management, and Prevention of Rheumatoid Arthritis: A Comprehensive …
Dose: None vs: None Outcome: RA risk and disease activity 效果: None None

研究人群: Patients with rheumatoid arthritis

Review
Hypoparathyroidism: diagnosis, management and emerging therapies.
Dose: None vs: None Outcome: None 效果: None None

研究人群: None

Systematic Review
Modulating inflammation and oxidative stress in rheumatoid arthritis: a systematic review of nutraceutical interventions.
Dose: None vs: None Outcome: None 效果: None None

研究人群: Systematic review of nutraceuticals in rheumatoid arthritis

Controlled Clinical Trial 26 weeks
Effects of Vitamin D Supplementation on Fatigue and Disease Activity in Systemic Lupus Erythematosus.
Dose: 4000 IU or 8000 IU daily vs: No supplementation Outcome: Fatigue (FACIT-Fatigue, FSS) and disease activity (SELENA-SLEDAI) 效果: None None

研究人群: SLE patients (EULAR/ACR 2019 criteria)

Review
Epstein-Barr virus, vitamin D and the immune response: connections with consequences for multiple sclerosis.
Dose: None vs: None Outcome: Neuroprotection 效果: None None

研究人群: None

Key Statistics

3

研究数量

25871

受试者

Positive

A

等级

Referenced Papers

Nature reviews. Endocrinology 2025 14 次引用
Autoimmunity reviews 2024 6 次引用
Biomolecules 2023 70 次引用
Endocrine connections 2022 50 次引用
Pathophysiology : the … 2022 24 次引用
Frontiers in bioscience … 2022 17 次引用
BMJ (Clinical research … 2022 9 次引用
Medical sciences (Basel, … 2021 157 次引用
Calcified tissue international 2020 185 次引用
Acta biochimica Polonica 2020 10 次引用
Advances in experimental … 2020 8 次引用
Journal of autoimmunity 2019 604 次引用
International journal of … 2019 109 次引用
Bone 2019 62 次引用
Journal of research … 2018 48 次引用
Wiadomosci lekarskie (Warsaw, … 2018 2 次引用
Thyroid : official … 2017 170 次引用
Analytical biochemistry 2017 47 次引用
Clinical reviews in … 2017 46 次引用
Postepy dermatologii i … 2017 31 次引用
Scandinavian journal of … 2016 81 次引用
Postepy dermatologii i … 2016 59 次引用
Indian dermatology online … 2016 51 次引用
Current gastroenterology reports 2016 22 次引用
Frontiers in immunology 2015 102 次引用
Clinica chimica acta; … 2015 43 次引用
Healthcare (Basel, Switzerland) 2015 7 次引用
F1000prime reports 2014 79 次引用
Pediatric clinics of … 2014 25 次引用
Clinical reviews in … 2013 259 次引用
British journal of … 2013 156 次引用
Clinics and research … 2013 56 次引用
Global advances in … 2013 19 次引用
Presse medicale (Paris, … 2013 4 次引用
Journal of investigative … 2011 563 次引用
Vitamins and hormones 2011 25 次引用
Molecular oncology 2011
Acta medica Indonesiana 2007 4 次引用
American family physician 2006

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

常用剂量

general:
600-800 IU/day
immunesupport:
1,000-2,000 IU/day
deficiencycorrection:
4,000-5,000 IU/day (under medical supervision)

上限: 4,000 IU/day (100 mcg)

研究中使用的剂量

剂量 持续时间 效果 N
None -- Positive --
None -- Positive --
None -- Mixed --
None -- Mixed --
4000 IU or 8000 IU daily 26 weeks Positive --
None -- Positive --
None -- Neutral --
None -- Neutral --

最佳服用时间: With a meal containing fat for better absorption

Safety & Side Effects

已报告的副作用

  • Hypercalcemia at very high doses (nausea, vomiting, weakness)
  • Kidney stones with excessive long-term use
  • Constipation
  • Metallic taste

已知相互作用

  • Thiazide diuretics (may increase risk of hypercalcemia)
  • Corticosteroids (reduce vitamin D absorption and metabolism)
  • Orlistat and cholestyramine (reduce fat-soluble vitamin absorption)
  • Statins (vitamin D may affect statin metabolism)

可耐受最高摄入量: 4,000 IU/day (100 mcg)

在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。

Frequently Asked Questions

Does Vitamin D help with 自身免疫性病症?
Based on 3 studies with 25,871 participants, there is strong evidence from multiple clinical trials that Vitamin D may support 自身免疫性病症 management. Our evidence grade is A (Strong Evidence).
How much Vitamin D should I take for 自身免疫性病症?
Studies have used various dosages. A commonly studied range is 600-800 IU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin D?
Reported side effects may include Hypercalcemia at very high doses (nausea, vomiting, weakness), Kidney stones with excessive long-term use, Constipation, Metallic taste. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin D and 自身免疫性病症?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 3 peer-reviewed studies with 25,871 total participants. The overall direction of effect is positive.

其他成分用于 自身免疫性病症

Vitamin D 用于其他健康状况

References

  1. [1] Elena Deseatnicova et al.. Nutrients. 2026. Impact of Nutritional Diet Therapy on Rheumatoid Arthritis Disease Activity. doi:10.3390/nu18030517 PubMed
  2. [2] Sarah Khan et al.. Nat Rev Endocrinol. 2025. Hypoparathyroidism: diagnosis, management and emerging therapies. doi:10.1038/s41574-024-01075-8 PubMed
  3. [3] Camila Leiva-Castro et al.. Inflammopharmacology. 2025. Modulating inflammation and oxidative stress in rheumatoid arthritis: a systematic review of nutraceutical interventions. doi:10.1007/s10787-025-01976-8 PubMed
  4. [4] Maria Polyzou et al.. Nutrients. 2025. The Role of Nutrition in the Development, Management, and Prevention of Rheumatoid Arthritis: A Comprehensive Review. doi:10.3390/nu17243826 PubMed
  5. [5] Oana Raluca Predescu et al.. Cureus. 2025. Effects of Vitamin D Supplementation on Fatigue and Disease Activity in Systemic Lupus Erythematosus. doi:10.7759/cureus.78830 PubMed
  6. [6] Karen H Costenbader et al.. Arthritis Rheumatol. 2024. Vitamin D and Marine n-3 Fatty Acids for Autoimmune Disease Prevention: Outcomes Two Years After Completion of a Double-Blind, Placebo-Controlled … doi:10.1002/art.42811 PubMed
  7. [7] Bhavani Sowndharya Balamurugan et al.. Immun Ageing. 2024. Micro nutrients as immunomodulators in the ageing population: a focus on inflammation and autoimmunity. doi:10.1186/s12979-024-00492-7 PubMed
  8. [8] Atia Rasheed et al.. Front Immunol. 2024. Epstein-Barr virus, vitamin D and the immune response: connections with consequences for multiple sclerosis. doi:10.3389/fimmu.2024.1503808 PubMed
  9. [9] Gunnar Houen. Autoimmun Rev. 2024. Auto-immuno-deficiency syndromes. doi:10.1016/j.autrev.2024.103610 PubMed
  10. [10] Ling-Jun Ho et al.. Biochem Pharmacol. 2024. Vitamin D and systemic lupus erythematosus: Causality and association with disease activity and therapeutics. doi:10.1016/j.bcp.2024.116417 PubMed
  11. [11] Siddhi B Chikhalkar et al.. Indian Dermatol Online J. 2024. Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata. doi:10.4103/idoj.idoj_535_23 PubMed
  12. [12] Savino Sciascia et al.. Nutrients. 2024. The Interconnection Between Systemic Lupus Erythematosus and Diet: Unmet Needs, Available Evidence, and Guidance-A Patient-Driven, Multistep-Approach Study. doi:10.3390/nu16234132 PubMed
  13. [13] Lambros Athanassiou et al.. Biomolecules. 2023. Vitamin D and Autoimmune Rheumatic Diseases. doi:10.3390/biom13040709 PubMed
  14. [14] Elena Nikiphorou et al.. Autoimmun Rev. 2023. Nutrition and its role in prevention and management of rheumatoid arthritis. doi:10.1016/j.autrev.2023.103333 PubMed
  15. [15] Ioanna Aggeletopoulou et al.. Am J Pathol. 2023. Vitamin D and Microbiome: Molecular Interaction in Inflammatory Bowel Disease Pathogenesis. doi:10.1016/j.ajpath.2023.02.004 PubMed
  16. [16] Hanane Touil et al.. Front Immunol. 2023. Differential impact of environmental factors on systemic and localized autoimmunity. doi:10.3389/fimmu.2023.1147447 PubMed
  17. [17] Filip Lebiedziński et al.. Nutrients. 2023. Impact of Vitamin D on Immunopathology of Hashimoto's Thyroiditis: From Theory to Practice. doi:10.3390/nu15143174 PubMed
  18. [18] Sizheng Steven Zhao et al.. Semin Arthritis Rheum. 2023. Associations between vitamin D and autoimmune diseases: Mendelian randomization analysis. doi:10.1016/j.semarthrit.2023.152238 PubMed
  19. [19] Yilan Zeng et al.. Mini Rev Med Chem. 2023. The Role of VD/VDR Signaling Pathway in Autoimmune Skin Diseases. doi:10.2174/1389557523666221124123206 PubMed
  20. [20] Fatemeh Mokhtari et al.. J Cosmet Dermatol. 2023. Inverse correlation between vitamin D and CRP levels in alopecia areata: A pilot study. doi:10.1111/jocd.15994 PubMed
  21. [21] Manisha Singh Basukala et al.. J Nepal Health Res Counc. 2023. Determination of Serum 25-Hydroxyvitamin D Levels in Patients with Alopecia Areata. doi:10.33314/jnhrc.v20i3.4408 PubMed
  22. [22] Jill Hahn et al.. BMJ. 2022. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. doi:10.1136/bmj-2021-066452 PubMed
  23. [23] Aniceta A Mikulska et al.. Int J Mol Sci. 2022. Metabolic Characteristics of Hashimoto's Thyroiditis Patients and the Role of Microelements and Diet in the Disease Management-An Overview. doi:10.3390/ijms23126580 PubMed
  24. [24] Jane Fletcher et al.. Endocr Connect. 2022. Autoimmune disease and interconnections with vitamin D. doi:10.1530/EC-21-0554 PubMed
  25. [25] Yanbin Dong et al.. Nutrients. 2022. Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL … doi:10.3390/nu14245307 PubMed
  26. [26] Irina V Belyaeva et al.. Pathophysiology. 2022. Tuberculosis and Autoimmunity. doi:10.3390/pathophysiology29020022 PubMed
  27. [27] Valeria Dipasquale et al.. Front Biosci (Landmark Ed). 2022. Vitamin D in Prevention of Autoimmune Diseases. doi:10.31083/j.fbl2710288 PubMed
  28. [28] Yamei Gao et al.. J Cosmet Dermatol. 2022. Evaluation of several immune and inflammatory indicators and their association with alopecia areata. doi:10.1111/jocd.14504 PubMed
  29. [29] Karen H Costenbader. BMJ. 2022. Vitamin D and fish oil supplements and risk of autoimmune disease. doi:10.1136/bmj.o243 PubMed
  30. [30] E Lubberts. Ned Tijdschr Geneeskd. 2022. [Vitamin D like one of few prevention possibilities for autoimmune diseases?]. PubMed
  31. [31] Krishna C Thandra et al.. Med Sci (Basel). 2021. Epidemiology of Non-Hodgkin's Lymphoma. doi:10.3390/medsci9010005 PubMed
  32. [32] Giovanna Borriello et al.. Int J Environ Res Public Health. 2021. Alopecia Universalis Occurring after Alemtuzumab Treatment for Multiple Sclerosis. A Two-Year Follow-Up of Two Patients. doi:10.3390/ijerph18147338 PubMed
  33. [33] Felix Paolo J Lizarondo et al.. JAAD Int. 2021. Determination of serum 25-hydroxyvitamin D levels in patients with alopecia areata and their comparison with levels in healthy controls: A … doi:10.1016/j.jdin.2021.07.008 PubMed
  34. [34] Chiara Gioia et al.. Nutrients. 2020. Dietary Habits and Nutrition in Rheumatoid Arthritis: Can Diet Influence Disease Development and Clinical Manifestations? doi:10.3390/nu12051456 PubMed
  35. [35] Stephanie R Harrison et al.. Calcif Tissue Int. 2020. Vitamin D, Autoimmune Disease and Rheumatoid Arthritis. doi:10.1007/s00223-019-00577-2 PubMed
  36. [36] Inês Henriques Vieira et al.. Nutrients. 2020. Vitamin D and Autoimmune Thyroid Disease-Cause, Consequence, or a Vicious Cycle? doi:10.3390/nu12092791 PubMed
  37. [37] Stefan Tukaj. Acta Biochim Pol. 2020. Vitamin D in autoimmune bullous disease. doi:10.18388/abp.2020_2905 PubMed
  38. [38] Vera Sau-Fong Chan. Adv Exp Med Biol. 2020. Epigenetics in Multiple Sclerosis. doi:10.1007/978-981-15-3449-2_12 PubMed
  39. [39] Andrea Fava et al.. J Autoimmun. 2019. Systemic lupus erythematosus: Diagnosis and clinical management. doi:10.1016/j.jaut.2018.11.001 PubMed
  40. [40] Michal A Zmijewski. Int J Mol Sci. 2019. Vitamin D and Human Health. doi:10.3390/ijms20010145 PubMed
  41. [41] Xia Jiang et al.. Bone. 2019. The genetics of vitamin D. doi:10.1016/j.bone.2018.10.006 PubMed
  42. [42] Hans-Klaus Goischke. Ther Clin Risk Manag. 2019. Vitamin D supplementation for the prevention or depletion of side effects of therapy with alemtuzumab in multiple sclerosis. doi:10.2147/TCRM.S188941 PubMed
  43. [43] Seyed-Amir Tabatabaeizadeh et al.. J Res Med Sci. 2018. Vitamin D, the gut microbiome and inflammatory bowel disease. doi:10.4103/jrms.JRMS_606_17 PubMed
  44. [44] Katarzyna Kolarz et al.. Wiad Lek. 2018. [Early reumatoid arthritis]. PubMed
  45. [45] Shiqian Hu et al.. Thyroid. 2017. Multiple Nutritional Factors and the Risk of Hashimoto's Thyroiditis. doi:10.1089/thy.2016.0635 PubMed
  46. [46] Giorgia Bizzaro et al.. Isr Med Assoc J. 2017. Vitamin D and Autoimmune Diseases: Is Vitamin D Receptor (VDR) Polymorphism the Culprit? PubMed
  47. [47] William J Griffiths et al.. Anal Biochem. 2017. Cholesterolomics: An update. doi:10.1016/j.ab.2017.01.009 PubMed
  48. [48] Larissa Lumi Watanabe Ishikawa et al.. Clin Rev Allergy Immunol. 2017. Vitamin D Deficiency and Rheumatoid Arthritis. doi:10.1007/s12016-016-8577-0 PubMed
  49. [49] Seval Erpolat et al.. Postepy Dermatol Alergol. 2017. 25-hydroxyvitamin D status in patients with alopecia areata. doi:10.5114/ada.2017.67847 PubMed
  50. [50] Ichiro Takada et al.. Curr Med Chem. 2017. Control of Inflammatory Bowel Disease and Colorectal Cancer by Synthetic Vitamin D Receptor Ligands. doi:10.2174/0929867323666161202145509 PubMed
  51. [51] Jin Lin et al.. PLoS One. 2016. Serum Vitamin D Level and Rheumatoid Arthritis Disease Activity: Review and Meta-Analysis. doi:10.1371/journal.pone.0146351 PubMed
  52. [52] Y Rosen et al.. Scand J Rheumatol. 2016. Vitamin D and autoimmunity. doi:10.3109/03009742.2016.1151072 PubMed
  53. [53] Ebru Karagün et al.. Postepy Dermatol Alergol. 2016. The role of serum vitamin D levels in vitiligo. doi:10.5114/pdia.2016.59507 PubMed
  54. [54] Ola Ahmed Bakry et al.. Indian Dermatol Online J. 2016. Serum Vitamin D in patients with alopecia areata. doi:10.4103/2229-5178.190504 PubMed
  55. [55] Berkeley N Limketkai et al.. Curr Gastroenterol Rep. 2016. Vitamin D and the Pathogenesis of Inflammatory Bowel Disease. doi:10.1007/s11894-016-0526-9 PubMed
  56. [56] Jiying Wang et al.. Nutrients. 2015. Meta-analysis of the association between vitamin D and autoimmune thyroid disease. doi:10.3390/nu7042485 PubMed
  57. [57] Colleen Elizabeth Hayes et al.. Front Immunol. 2015. Vitamin D Actions on CD4(+) T Cells in Autoimmune Disease. doi:10.3389/fimmu.2015.00100 PubMed
  58. [58] Aslı Aksu Çerman et al.. J Drugs Dermatol. 2015. Topical Calcipotriol Therapy for Mild-to-Moderate Alopecia Areata: A Retrospective Study. PubMed
  59. [59] Maria O'Sullivan. Proc Nutr Soc. 2015. Vitamin D as a novel therapy in inflammatory bowel disease: new hope or false dawn? doi:10.1017/S0029665114001621 PubMed
  60. [60] Wen-Chih Liu et al.. Clin Chim Acta. 2015. Vitamin D and immune function in chronic kidney disease. doi:10.1016/j.cca.2015.08.011 PubMed
  61. [61] Aaron S Bancil et al.. Healthcare (Basel). 2015. The Role of Vitamin D in Inflammatory Bowel Disease. doi:10.3390/healthcare3020338 PubMed
  62. [62] Robyn M Lucas et al.. F1000Prime Rep. 2014. Vitamin D and immunity. doi:10.12703/P6-118 PubMed
  63. [63] Nanette B Silverberg. Pediatr Clin North Am. 2014. Pediatric vitiligo. doi:10.1016/j.pcl.2013.11.008 PubMed
  64. [64] Nancy Agmon-Levin et al.. Clin Rev Allergy Immunol. 2013. Vitamin D in systemic and organ-specific autoimmune diseases. doi:10.1007/s12016-012-8342-y PubMed
  65. [65] S Basit. Br J Biomed Sci. 2013. Vitamin D in health and disease: a literature review. doi:10.1080/09674845.2013.11669951 PubMed
  66. [66] Roberto d'Ovidio et al.. Dermatoendocrinol. 2013. Reduced level of 25-hydroxyvitamin D in chronic/relapsing Alopecia Areata. doi:10.4161/derm.24411 PubMed
  67. [67] Daniel S Smyk et al.. Clin Res Hepatol Gastroenterol. 2013. Vitamin D in autoimmune liver disease. doi:10.1016/j.clinre.2013.05.016 PubMed
  68. [68] Alan Gaby. Glob Adv Health Med. 2013. Multiple sclerosis. doi:10.7453/gahmj.2013.2.1.009 PubMed
  69. [69] Yoland Schoindre et al.. Presse Med. 2013. [Vitamin D and autoimmunity]. doi:10.1016/j.lpm.2013.06.014 PubMed
  70. [70] Cynthia Aranow. J Investig Med. 2011. Vitamin D and the immune system. doi:10.2310/JIM.0b013e31821b8755 PubMed
  71. [71] Sandro Ardizzone et al.. Vitam Horm. 2011. Vitamin D and inflammatory bowel disease. doi:10.1016/B978-0-12-386960-9.00016-2 PubMed
  72. [72] Sinead Field et al.. Mol Oncol. 2011. Melanoma and vitamin D. doi:10.1016/j.molonc.2011.01.007 PubMed
  73. [73] Netta Shoenfeld et al.. Nat Clin Pract Rheumatol. 2009. The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease. doi:10.1038/ncprheum0989 PubMed
  74. [74] Eka Ginanjar et al.. Acta Med Indones. 2007. Vitamin D and autoimmune disease. PubMed
  75. [75] Barbara L Mark et al.. J Am Diet Assoc. 2006. Vitamin D and autoimmune disease--implications for practice from the multiple sclerosis literature. doi:10.1016/j.jada.2005.12.009 PubMed
  76. [76] Kelly M Luba et al.. Am Fam Physician. 2006. Chronic plaque psoriasis. PubMed
  77. [77] M T Cantorna. Proc Soc Exp Biol Med. 2000. Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? doi:10.1046/j.1525-1373.2000.22333.x PubMed

FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。